Application Area
The term CGT stands for Cell and Gene Therapy and describes a range of new personalized therapies that are promising in the treatment of some diseases. For which diseases is the therapy suitable?
Michael Eder
May 11, 2020
Application Area
According to information from the biopharmaceutical industry, the loss rate for CAR-T cell therapies is over 1%. This means that it can be assumed that currently only 99 out of 100 people receive a fully functional Car-T therapy. Read here!
Michael Eder
February 11, 2019
Application Area
The National Health Service (NHS) of Great Britain, confirms the use of CAR-T Cell Therapy Kymriah on an 11-year-old leukaemia patient. However, it is not certain whether the vital therapy will make its way into society. Read it for yourself!
Michael Eder
February 8, 2019